CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275414423
- Phone
- (650) 822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- 4 Open-market buy Director bought 3,200 shares at $5.48 ($17,536)
- 4 Planned sale EVP & CHIEF INNOVATION OFFICER sold 5,500 shares at $5.95 ($32,725)
- 144 Insider Sale of Securities
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market buy Director bought 3,200 shares at $6.24 ($19,968)
- 8-K Event Other events
- 4 Open-market sale EVP & CHIEF BUSINESS OFFICER sold 784 shares at $6.02 ($4,720)
- 4 Open-market sale EVP & CHIEF FINANCIAL OFFICER sold 1,104 shares at $6.03 ($6,657)
- 4 Open-market sale EVP & CHIEF INNOVATION OFFICER sold 1,106 shares at $6.02 ($6,658)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market buy Director bought 3,200 shares at $5.00 ($16,000)
- 8-K Event Other events
- 8-K Event Shareholder vote results
Page 10 of 27 · 524 filings